Related Experiment Video
Updated: Sep 10, 2025
06:46
Ex Vivo Corneal Organ Culture Model for Wound Healing Studies
Published on: February 15, 2019
11.9K
Amphiregulin and Fibrosis: Existing Evidence and Future Directions
Margherita Sisto1, Sabrina Lisi1
1Department of Translational Biomedicine and Neuroscience (DiBraiN), Section of Human Anatomy and Histology, University of Bari "Aldo Moro", I-70124 Bari, Italy.
International Journal of Molecular Sciences
|August 28, 2025
Summary
Amphiregulin (AREG) bridges inflammation and fibrosis in autoimmune diseases. Targeting AREG-mediated pathways offers potential new therapies for fibrotic conditions, improving organ function and patient quality of life.
Area of Science:
- Fibrotic diseases
- Autoimmune disorders
- Molecular biology
Background:
- Fibrotic diseases involve excessive extracellular matrix deposition, altering tissue structure and organ function.
- Epithelial-to-mesenchymal transition (EMT) activation is a key driver of fibrosis, often linked to chronic inflammation in autoimmune diseases.
- Current treatments for fibrotic autoimmune diseases are limited due to complex, intersecting molecular pathways.
Purpose of the Study:
- To review the role of Amphiregulin (AREG) in fibrotic processes within autoimmune diseases.
- To explore emerging therapeutic strategies targeting AREG-mediated pathways.
- To understand AREG's function as a molecular bridge between inflammation and fibrosis.
Main Methods:
- Literature review focusing on fibrotic diseases and autoimmune conditions.
- Analysis of molecular mechanisms involving Amphiregulin (AREG) and its interaction with the epidermal growth factor receptor (EGFR).
- Evaluation of emerging targeted interventions for AREG-mediated pathways.
Main Results:
- Amphiregulin (AREG) acts as a crucial molecular link between inflammatory and fibrotic mechanisms.
- Emerging data highlight AREG's significant role in the pathogenesis of fibrotic autoimmune diseases.
- Targeting AREG-EGFR interactions presents a promising therapeutic avenue.
Conclusions:
- Amphiregulin (AREG) is a key player in the fibrotic progression of autoimmune diseases.
- Modulating AREG-mediated pathways offers a novel therapeutic strategy.
- Further research into AREG's role can lead to improved treatments for fibrotic conditions.
Related Concept Videos
01:09Introduction to Fibroblasts
3.2K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.2K
01:56Structural Protein Function
28.3K
Structural proteins are a category of proteins responsible for functions ranging from cell shape and movement to providing support to major structures such as bones, cartilage, hair, and muscles. This group includes proteins such as collagen, actin, myosin, and keratin.
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...
28.3K